Skip to search formSkip to main contentSkip to account menu

picotamide

Known as: 4-methoxy-N,N'-bis(3-pyridinylmethyl)-1,3-benzenedicarboxamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Picotamide is an antiplatelet drug which inhibits thromboxane A2 (TxA2) synthase and antagonizes TxA2 receptors. In the ADEP… 
1999
1999
Background: Dialysis access occlusion is the most common cause of hospitalization and a frequent indirect cause of mortality in… 
1998
1998
In a controlled, randomized, 6-year trial the safety and efficacy of picotamide, a dual-action antithromboxane agent, were… 
1997
1997
Pancera P, Sansone S, Secchi S, Covi G, Lechi A (University of Verona, Verona, Italy). The effects of thromboxane A2 inhibition… 
1996
1996
BACKGROUND: Inflammatory bowel disease is associated with increased mucosal release of eicosanoids. Among these, thromboxane A2… 
1995
1995
BACKGROUND AND PURPOSE We assessed the effects of long-term treatment with picotamide, an antiplatelet agent with dual… 
1994
1994
1 Picotamide was shown to inhibit platelet binding of thromboxane A2 (TxA2)‐mimetics and to cause a reduction of TxA2 platelet… 
1994
1994
BackgroundThe role of thromboxane A2 (TxA2) in unstable angina has not yet been defined. TxA2 receptor antagonists may be of… 
1993
1993
We investigated the short-term effect of the TXB inhibitor picotamide on albuminuria induced by exercise in 15 microalbuminuric…